You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Argentina Patent: 058289


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 058289

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,534,281 Sep 8, 2030 Glaxo Grp Ltd BREO ELLIPTA fluticasone furoate; vilanterol trifenatate
8,534,281 Sep 8, 2030 Glaxosmithkline TRELEGY ELLIPTA fluticasone furoate; umeclidinium bromide; vilanterol trifenatate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR058289

Last updated: August 7, 2025


Introduction

Patent AR058289, granted in Argentina, represents a strategic intellectual property asset within the pharmaceutical sector. This analysis provides a comprehensive review of its scope and claims, contextualized within the broader patent landscape in Argentina. The aim is to inform business decisions and patent strategy for stakeholders involved in drug development, licensing, and commercialization.


Overview of Patent AR058289

AR058289, granted by the National Institute of Industrial Property (INPI), encompasses intellectual property rights related to a specific pharmaceutical invention. While detailed claim language and specification are essential for complete understanding, this analysis synthesizes publicly available information, emphasizing claim scope, relevant positioning within patent classifications, and the landscape implications.


Scope of the Patent

The scope of Patent AR058289 centers on a novel pharmaceutical compound or a specific formulation thereof. Typically, Argentine patents in pharmacology aim to protect innovative molecules, dosage forms, or preparation methods with demonstrated therapeutic advantages.

The patent’s scope likely includes:

  • Chemical Composition: Definition of the active pharmaceutical ingredient (API) or its derivatives.
  • Therapeutic Use: Indications or methods of use, e.g., treating certain diseases or conditions.
  • Manufacturing Process: Specific methods for synthesizing the compound or formulation.
  • Formulation Features: Novel delivery mechanisms or excipient combinations that enhance stability, bioavailability, or patient compliance.

When considering Argentine patent law, scope is bounded by the claims and their interpretation, which typically refer to the precise elements or steps that constitute the protected invention.


Claims Analysis

While the detailed actual claim language is necessary for exact interpretation, general patterns in pharmaceutical patents inform the likely structure:

  • Product Claims: Covering the chemical entity, such as a new molecular structure or a pharmacologically active derivative.
  • Method Claims: Encompassing methods of synthesis, formulation, or specific therapeutic applications.
  • Use Claims: Protecting novel methods for treating particular diseases with the compound.
  • Formulation Claims: Protecting specific pharmaceutical compositions or delivery systems utilizing the compound.

In Argentina, patent claims are assessed based on clarity (Article 33 of the IP Law), novelty, inventive step, and industrial applicability. Broad product claims are often balanced against narrower dependent claims that specify particular embodiments or features.

Potential Claim Strategies:

  • Core Product Claims: Covering the broadest form of the active compound.
  • Intermediate Claims: Detailing specific derivatives or formulations.
  • Use Claims: To secure monopolies over therapeutic applications.

Patent Landscape in Argentina

1. Existing Patent Families:
Argentina’s pharmaceutical patent landscape is characterized by both local filings and international patent family members. Major pharmaceutical companies tend to file patents covering key innovations in Argentina, often in conjunction with regional filings. Patent AR058289 sits within this ecosystem, likely functioning as a critical component of a broader patent family.

2. Patent Trends:
Recent years highlight increased patent filings concerning biopharmaceuticals, targeted therapies, and complex formulations. The legal framework mirrors international standards, focusing on clarity, novelty, and inventive step, but often encounters challenges due to strict examination criteria and the requirement for specific industrial applicability.

3. Patent Litigation and Enforcement:
Argentina’s regulatory environment permits patent enforcement through civil litigation. Patent AR058289 might be part of disputes over infringement or validity, influencing strategic considerations for licensing or commercialization.

4. Competitor and Patent Thickets:
The landscape features overlapping patents related to chemical derivatives, formulations, and secondary indications. Navigating this thicket requires detailed patent landscaping and freedom-to-operate analyses.


Legal Status and Strategic Implications

  • Validity and Term:
    As a granted patent, AR058289 confers exclusivity typically lasting 20 years from the filing date, provided maintenance fees are paid. Its validity also depends on examination and potential oppositions.

  • Scope and Enforcement:
    Narrow claims could limit enforcement, while broad claims offer stronger market leverage. Clear, defensible claims are essential given Argentina’s robust patent examination processes.

  • Freedom to Operate:
    Companies need to assess the patent portfolio landscape, especially if AR058289 claims compounds or methods similar to other patents, to avoid infringement and facilitate licensing negotiations.


Conclusion

Patent AR058289 secures valuable rights over a specific pharmaceutical invention within Argentina. Its scope, characterized primarily by chemical and therapeutic claims, must be carefully mapped against the Argentine patent landscape to optimize commercialization and licensing strategies.

A thorough understanding of its claims and legal status informs risk management, especially considering the local patent enforcement environment and potential opposition or invalidation risks.


Key Takeaways

  • Patent Scope: Focused on a pharmaceutical compound, formulation, or method, with details contingent upon specific claim language.
  • Claims Strategy: Likely combines broad product claims with narrower dependent or use claims, providing a balanced protective scope.
  • Landscape Position: Embedded within a growing pharmaceutical patent environment, requiring ongoing landscape monitoring for freedom-to-operate insights.
  • Legal and Commercial Utility: Validity and enforceability depend on compliance with Argentine patent law and strategic claim drafting.
  • Strategic Action: Companies should conduct comprehensive patent clearance and landscape analyses to leverage AR058289 without infringing existing rights.

FAQs

1. What is the main novelty protected by Patent AR058289?
The patent likely covers a novel pharmaceutical compound or formulation with unique therapeutic or manufacturing features, as specified in its claims.

2. How does Argentine patent law influence the scope of pharmaceutical patents?
Argentina emphasizes clarity, novelty, and industrial applicability, resulting in potentially narrower claims. Broad claims must be sufficiently supported and distinguishable.

3. Can AR058289 be enforced against competitors?
Yes, if the claims are valid and the product or process infringes, enforcement through civil litigation is possible, but careful claim interpretation is essential.

4. How does the patent landscape in Argentina impact drug development?
A competitive landscape with overlapping patents necessitates thorough freedom-to-operate analyses before launching new products.

5. What should patent holders consider for maintaining patent validity?
Regular payment of maintenance fees, monitoring of potential invalidity challenges, and updating patent strategies to adapt to evolving legal standards are critical.


Sources:
[1] Argentine Patent Law, INPI Official Documentation.
[2] WIPO Patent Landscape Reports, Latin America.
[3] Industry Patent Filings Database, INPI Argentina.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.